Reuters logo
BRIEF-Jiangxi Boya Bio-pharmaceutical expects Q1 to Q3 2016 net profit to increase by 60 to 90 pct
October 12, 2016 / 5:35 AM / a year ago

BRIEF-Jiangxi Boya Bio-pharmaceutical expects Q1 to Q3 2016 net profit to increase by 60 to 90 pct

Oct 12 (Reuters) - Jiangxi Boya Bio-pharmaceutical Co Ltd :

* Says net profit for Q1 to Q3 of 2016 expected to increase by 60 percent to 90 percent, or to be 166.9 million to 198.2 million yuan

* Says the net profit of Q1 to Q3 of 2015 was 104.3 million yuan

Source text in Chinese: goo.gl/ZoTKr1

Further company Coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below